See All Slides - tctmd.com

Slides

Presentation TCT 2012

Selection and Use of Coils for Embolization of Perforations

Presenter: John Rundback

October 23, 2012

Presentation TCT 2012

Abluminus (Envision Scientific) Program Update

Presenter: Sameer Dani

October 23, 2012

Presentation TCT 2012

Attributes of the Perfect LAA Closure Device: What All the Companies Should Strive For

Presenter: Horst Sievert

October 23, 2012

Presentation TCT 2012

TCT-73. Non-Invasive Evaluation of Coronary Artery Collateral Flow Using Computed Tomographic Angiography

Presenter: Jin-Ho Choi

October 23, 2012

Presentation TCT 2012

Is Ischemia a Marker of Plaque Vulnerability and Future Thrombosis?

Presenter: Bernard De Bruyne

October 23, 2012

Presentation TCT 2012

Case 1: During a TAVR

Presenter: Susheel Kodali

October 23, 2012

Presentation TCT 2012

TCT-49. A Comparison of 5 mg Prasugrel with 75 mg Clopidogrel in Very Elderly Coronary Artery Disease Patients: Pharmacodynamics and Rates of High on-Treatment Reactivity

Presenter: Joseph Jakubowski

October 23, 2012

Presentation TCT 2012

What Will It Take for Focal Therapy of Vulnerable Plaque to Become a Reality? Preclinical and Clinical Insights

Presenter: Patrick Serruys

October 23, 2012

Presentation TCT 2012

TCT-71. Intravascular Ultrasound-guided Systematic Two-stent Techniques for Coronary Bifurcation Lesions Reduced Late Stent Thrombosis and ST-elevation Myocardial Infarction

Presenter: Shao Liang Chen

October 23, 2012

Presentation TCT 2012

Vulnerable Plaque Is a Systemic Inflammatory and Vascular Disease

Presenter: Valentin Fuster

October 23, 2012

Advertisement

Slides

Selection and Use of Coils for Embolization of Perforations

Abluminus (Envision Scientific) Program Update

Attributes of the Perfect LAA Closure Device: What All the Companies Should Strive For

TCT-73. Non-Invasive Evaluation of Coronary Artery Collateral Flow Using Computed Tomographic Angiography

Is Ischemia a Marker of Plaque Vulnerability and Future Thrombosis?

Case 1: During a TAVR

TCT-49. A Comparison of 5 mg Prasugrel with 75 mg Clopidogrel in Very Elderly Coronary Artery Disease Patients: Pharmacodynamics and Rates of High on-Treatment Reactivity

What Will It Take for Focal Therapy of Vulnerable Plaque to Become a Reality? Preclinical and Clinical Insights

TCT-71. Intravascular Ultrasound-guided Systematic Two-stent Techniques for Coronary Bifurcation Lesions Reduced Late Stent Thrombosis and ST-elevation Myocardial Infarction

Vulnerable Plaque Is a Systemic Inflammatory and Vascular Disease

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content